Vera Therapeutics, Inc. (VERA)
46.46
-2.25
(-4.62%)
USD |
NASDAQ |
Jan 12, 16:00
46.10
-0.36
(-0.77%)
Pre-Market: 09:09
Vera Therapeutics EPS Diluted (Quarterly): -1.258 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
| MannKind Corp. | 0.0256 |
| Janux Therapeutics, Inc. | -0.392 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -80.29M |
| Total Expenses (Quarterly) | 80.29M |
| Enterprise Value | 2.550B |
| Earnings Yield | -8.58% |
| Normalized Earnings Yield | -8.585 |